Millie
your market intelligence analyst
Search Results
413 results
Your search is now limited to «COPD in the News» expert search.
ETHealthWorld (India) 08/17/2019 02:33
They found that people living with HIV are at an increased risk of contracting specific diseases and illnesses, some of which are more commonly associated with ageing.
More from ETHealthWorld (India):
ClinicalTrials.gov 08/12/2019 08:16
Eligible patients must have a history of ≥2 moderate and/or severe COPD exacerbations in the previous year despite receiving triple (ICS/LABA/LAMA) background therapy.
More from ClinicalTrials.gov:
COPD News Today 08/09/2019 12:00
... released additional results of a Phase 2 trial demonstrating that maintenance treatment with its dry powder inhaler (DPI) formulation of ensifentrine (RPL554) is safe, and significantly improves lung function in people with moderate to severe chronic obstructive pulmonary disease (COPD.
More from COPD News Today:
European Respiratory Journal 08/08/2019 07:29
Using Google Trends to investigate global COPD awareness.
More from European Respiratory Journal:
Mepolizumab, a humanized monoclonal antibody against interleukin-5 (IL-5), may have a therapeutic effect in a subgroup of patients with COPD and eosinophilic airway inflammation.
More from International Journal of COPD:
PharmaTimes 08/06/2019 07:28
All of the primary and secondary lung function endpoints were met in a Phase II trial for Verona’s dry powder inhaler (DPI) formulation of its lead development product, ensifentrine, for the maintenance treatment of chronic obstructive pulmonary disease (COPD), the company has reported.
More from PharmaTimes:
GlobeNewswire 08/05/2019 02:00
Jan-Anders Karlsson, PhD, CEO of Verona Pharma, said: “These very promising data with the DPI formulation support our view that ensifentrine is an effective bronchodilator in COPD patients, whether administered as a dry powder via a handheld inhaler or as a suspension via a nebulizer.
More from GlobeNewswire:
Adding low-dose oral theophylline to inhaled corticosteroids did not reduce exacerbations over 1 year.
More from U.S. Department of Health & Human Services - HHS.gov (HHS):
PharmiWeb.com 07/23/2019 23:06
With no effective broad-spectrum antiviral treatment on the market, Synairgen’s inhaled IFN-beta may provide a novel approach for COPD patients, with the potential to greatly improve the patient's defences against viral infection, reduce exacerbations, increase quality of life and reduce hospitalisations.
More from PharmiWeb.com:
COPD.net 07/23/2019 09:36
Chronic Obstructive Pulmonary Disease (COPD) affects 380 million people around the world, and those numbers are increasing every year.1 COPD is a chronic, progressive disease of the lungs for which there is no known cure.
More from COPD.net:
Business Wire 07/22/2019 10:00
Asthma and COPD patients can also find solutions to help them better manage their chronic condition on the platform.
More from Business Wire:
BIOENGINEER.ORG 07/15/2019 08:49
Dr. Chapman’s $100,000 award will support his research into how non-invasive ventilation (NIV) can help improve sleep for people with both obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), known as COPD/OSA Overlap Syndrome.
More from BIOENGINEER.ORG:
Thorax 07/15/2019 04:35
Earlier research showed that one-third to half of COPD patients have not been diagnosed.
More from Thorax:
FeedNavigator (EU) 07/14/2019 11:07
Chronic obstructive pulmonary disease (COPD) increases the risk of RV dysfunction.
More from FeedNavigator (EU):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications